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Abstract:
Modern life is characterized by physical inactivity and poor food choices, which is often a prerequisite for unhealthy weight gain and
overweight/obesity.  These  factors  unlock  the  emergence  of  a  number  of  diseases  including  diabetes,  cardiovascular  problems,
different types of cancer, etc.
The pursuit of scientists to seek strategies to prevent, relieve and cure the patient leads to the usage of natural compounds of potential
beneficial effect. Polyphenols are a large group of naturally occurring secondary metabolites mainly found in plants and beverages.
The presence of these secondary metabolites seems to decrease the manifestation of miscellaneous disease-causing symptoms.
The purpose of this review is to synthesize information about polyphenols and their potential in controlling obesity and diabetes.
Polyphenols are considered as health-beneficial sources and thus could be involved in novel strategies for preventing diabetes and
obesity complications.
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1. INTRODUCTION
Nutrition is an important health factor, as the main recommendations for achieving it include the consumption of a
variety of foods. Nutritional knowledge is gained in the early years of development, thus promoting healthier choices at
an early stage of habitual development may lead to minimizing the display of 21st century diseases i.e. diabetes type 2,
obesity, heart complications, teeth decay, etc. with the help of adequate dietary assessment and food choices relevant to
nutritional requirements.
A well-balanced diet usually means the provision of the required nutrients for the different physiological groups.
People need a wide variety of nutrients in order to attain the anthropometric reference standards and lead an active life.
Nutrient balance most often means an equilibrium of the input and output calories. In order to make recommendations,
nutrient data is needed to propose a customary intake.
International experience has shown that food safety issues, as well as providing full and healthy food available to
the general population, reducing nutrient deficiencies, morbidity and mortality from a number of Noncommunicable
Diseases (NCDs) - cardiovascular disease, obesity, diabetes, hyperlipoproteinemias, certain cancers, etc., can be best
addressed by implementing a unified national food and nutrition policy with coordinated cross-sectoral activities [1].
According to the WHO, noncommunicable diseases kill 40 million people each year, equivalent to 70% of all deaths
globally.  People  of  all  age  groups,  regions  and  countries  are  affected  by  NCDs  but  raised  blood  pressure;
overweight/obesity; hyperglycemia (high blood glucose levels); and  hyperlipidemia (high levels of fat in the  blood) are
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the four key metabolic changes that increase the risk of NCDs [2]. Therefore the European Commission established a
coherent and comprehensive Community Strategy to address the issues of overweight and obesity and related health
issues [3] as well as the EU Action Plan on Childhood Obesity 2014-2020 [4].
2. DIABETES AND OBESITY
Diabetes (Diabetes mellitus) is a serious, lifelong, progressive endocrine disorder, which can influence the entire
body. It is characterized by hyperglycemia (high blood sugar (glucose) levels in the body) due to absolute or relative
insulin  production  dysfunction.  Diabetes  leads  to  serious  consequences  i.e.  limb  amputation,  kidney  failure,  heart
attack, stroke and blindness. In 2016, there are 3.7 million registered deaths due to diabetes. The three main types of
diabetes are type 1 (10% of all  diabetes),  type 2 (85% of all  diabetes)  and gestational  diabetes.  6th  April  2016 was
announced World Health Day: Beat diabetes, and according to the WHO global diabetes info gram, 422 million adults
have diabetes, which means that every 11th person has diabetes [5].
Type  1  diabetes  is  an  auto-immune  condition  in  which  the  cells  that  produce  insulin  are  destroyed  so  lifelong
treatment with insulin is required to prevent death. Type 2 diabetes, which may remain undetected for many years,
occurs when the body either stops producing enough insulin for its needs or becomes resistant to the effect of insulin
produced. The condition is progressive requiring lifestyle management (diet and exercise) at all stages. In this respect,
functional foods may be a promising strategy to address this issue as reported by Tessari and Lante [6]. These authors
studied the metabolic effects of a specifically designed functional bread, low in starch and rich in fibers in people with
type 2 diabetes mellitus. Over time, most people with type 2 diabetes will require oral drugs and/or insulin. Obesity is
only associated with type 2 diabetes and according to the WHO report every 3rd person is overweight and every 10th is
obese. The physical inactivity and unhealthy diet are the main contributors to being overweight and obese.
Women with gestational diabetes are at an increased risk of complications during pregnancy and at delivery. It can
occur at any stage of pregnancy, and does not usually cause any symptoms, but is more likely at 20 weeks or later.
Screening for gestational diabetes is between weeks 8 to 12 when a doctor evaluates the risk of gestational diabetes.
Women and their children are also at increased risk of type 2 diabetes in the future.
The likelihood and severity of type 2 diabetes are closely linked to Body Mass Index (BMI). A BMI above 30 is an
alarming symptom. The epidemic of diabetes has major health and socioeconomic impacts, especially in developing
countries. Obese people are seven times more likely to have diabetes, while overweight people are at only three times
greater risk compared to those of healthy weight [7].
There are several theories of why obesity is linked to diabetes type 2. One of them states that abdominal obesity
may cause fat cells to release pro-inflammatory chemicals, which lower the body sensitivity to insulin and disrupt its
ability to properly respond to insulin [8]. Scientists claim that obesity is most likely to trigger changes to the body's
metabolism that  cause  fat  tissue  to  release  increased amounts  of  fatty  acids,  glycerol,  hormones,  pro-inflammatory
cytokines and other factors that  are involved in the development of insulin resistance [9].  Studies with the skeletal
muscle of type 2 diabetic humans demonstrate impaired insulin activation of the IRS-1/PI3K/Akt signaling pathway,
which is a critical step in the regulation of glucose transport in response to insulin [10].
There is a clear association between increasing age and greater diabetes prevalence. In the UK, less than 2% of
people aged 16-34 years are estimated to have diabetes compared to 5.1% of people aged 35-54 years, 14.3% of people
aged 55-74 years and 16.5% of those aged over 75 years [11].
Both obesity and type 2 diabetes are strongly associated with an unhealthy diet and physical inactivity. Physical and
social environments are important influences on diet and physical activity behavior along with interrelated economic,
psychological and cultural factors [12]. Obesity and diabetes are characterized by both insulin resistance and endothelial
dysfunction as increased artery intima-media thickness, and increased vascular stiffness leading to substantial increases
in cardiovascular morbidity and mortality [13, 14].
Obesity is due primarily to an imbalance between caloric intake and activity. Obesity has rapidly become a serious
public health concern. Obesity and overweight are different stages of unhealthy weight. Overweight people are those
with  BMI  between  25  and  30,  while  obese  ones  are  those  with  BMI  over  30.  This  means  that  obese  people  have
accumulated excessive fat tissues in their body. Social inequalities in overweight and obesity are strong, especially
among women [15].  Absolute social  inequalities  were largest  in Hungary (11.6% obese rates in men and 18.3% in
women) and Spain (10% obese rates in men and 18.9% in women) across the education spectrum. Relative inequalities
with poor education (largest in France and Sweden) showed that poorly educated men are 3.2 and 2.8 times more likely
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to be obese than men with the higher education. According to Devaux and Sassi [15], USA and England had the highest
rates of obesity and overweight. Obesity levels are expected to be particularly high in the United States (47%), Mexico
(39%) and England (35%) by the year 2030.
On the contrary, the WHO foresees a weaker increase in obesity and overweight in Italy and Korea, with obesity
rates projected to be 13% and 9% in 2030, respectively. The level of obesity in France is projected to nearly match that
of Spain, at 21% in 2030. Obesity rates are projected to increase at a faster pace in Korea and Switzerland where rates
have been historically low [16].
3. POLYPHENOLS AND HUMAN HEALTH
Polyphenols  are  a  large  group  of  naturally  occurring  secondary  metabolites  mainly  found  in  plants  (fruits,
vegetables,  cereals  etc.)  and  beverages.  They  have  a  wide  variety  of  diverse  structures,  which  belong  to  two main
classes: non-flavonoids (particularly phenolic acids, stilbenes and lignans) and flavonoids, which are characterized by
the basic C6-C3-C6 skeleton (Fig. 1). The two aromatic rings within the flavonoid structure are linked by a heterocyclic
ring,  which  differs  in  the  degree  of  oxidation  and  leads  to  the  following  sub-classifications:  flavones,  flavonols,
isoflavones, flavanones, anthocyanins and flavanols, usually called catechins. Some of the widespread representatives
of  natural  phenolic  compounds  are  kaempherol  (flavonol),  quercetin  (flavonol),  luteolin  (flavone)  and  resveratrol
(stilbenoid) (Fig 1). Both luteolin and quercetin are associated with their protective effects on diabetic nephropathy and
retinopathy [17, 18]. Treatment with quercetin has the ability to abrogate hypertension progression induced by diabetes
together with amelioration of the exaggerated contractile responses of aorta. Studies have confirmed the efficacy of
resveratrol in type 2 diabetes. Furthermore, in vitro and in vivo studies have described resveratrol as a potent activator
of histone deacetylase Sirtuin1 (Sirt1) [19].
Fig. (1). Structure of flavonoid: A – structure of flavonoid skeleton; B – chemical structures of some dietary flavonoids.
Polyphenols are generally involved in defense against ultraviolet radiation or aggression by pathogens. In food, they
may  contribute  to  the  bitterness,  astringency,  color,  flavor,  odor  and  oxidative  stability.  Because  of  their  possible
beneficial effects on human health, polyphenols and other food phenolics are still increasing their scientific interest.
Studying the dietary polyphenol intake in Europe, Zamora et al.  [20] reported a large number of dietary individual
polyphenols  consumed  and  high  variability  of  their  intakes  between  European  populations,  in  particular  between
Mediterranean (MED) and non-MED countries. The main polyphenol contributors were established to be phenolic acids
(52.5-56.9%), except in men from MED countries and in the UK health-conscious group where they were flavonoids
(49.1-61.7%).  Coffee,  tea,  and fruit  were  the  most  important  food sources  of  total  polyphenols.  Zamora et  al.  [20]
reported that the consumption of 437 different individual polyphenols (including 94 consumed at 1 mg/day) had health-
promoting properties. The most abundant ones according to the above-mentioned authors were caffeoylquinic acids and
the proanthocyanidin olygomers and polymers [20].
The polyphenol  content  of  foods is  strongly influenced by the  methods of  culinary preparation.  The process  of
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peeling  of  fruits  and  vegetables,  for  example,  can  significantly  reduce  polyphenol  content,  not  only  because  these
substances are often present in high concentrations in the outer parts, but also due to enzymatic browning which occurs
after the breakdown of plant cell structure and the subsequent interaction between enzyme Polyphenol Oxidase (PPO)
and substrate during post-harvest stages leading to color alteration and antioxidant degradation as a consequence of the
phenolic oxidation. For this reason, the research of new eco-friendly systems for controlling PPO activity is focused on
innovative  non-thermal  technologies  and  bioactive  compounds  to  replace  the  conventional  thermal  treatments  and
traditional additives which could impair the sensory, nutritional and health properties of food products [21 - 26].
The process of heating, also, has an outstanding effect. About 75% of the initial quercetin content in tomatoes and
onions is lost after boiling for 15 min, 65% after cooking in a microwave oven, and 30% after frying. Potatoes contain
up to 190 mg chlorogenic acid/kg mainly in the skin [27]; so, an extensive loss occurs during culinary processes, and as
a result, no remaining phenolic acids are found in French fries [28]. Also, extraction by heating or boiling of green tea
leaves seems to increase the epimerization of tea catechins and therefore a lower recovery of bioactive compounds [29].
Polyphenols,  of  natural  origin,  are  potential  sources  of  various  beneficial  effects  -  anti-obesity,  anti-diabetic,
antihypertensive, anti-hyperlipidemic and anti-inflammatory effects [30]. Commonly consumed polyphenols such as
green tea catechins, especially epigallocatechin gallates, as well as resveratrol and curcumin are considered to impact
obesity and obesity-related inflammation. Dietary polyphenols are demonstrated to reduce viability of adipocytes and
proliferation of preadipocytes, suppress adipocyte differentiation and triglyceride accumulation, stimulate lipolysis and
fatty acid β-oxidation, and reduce inflammation. Furthermore, polyphenols can modulate signaling pathways including
the adenosine monophosphate-activated protein kinase, peroxisome proliferator-activated receptor γ, CCAAT/enhancer
binding  protein  α,  peroxisome  proliferator  activator  receptor  gamma  activator  1-alpha,  sirtuin  1,  sterol  regulatory
element binding protein-1c, uncoupling proteins 1 and 2, and nuclear factor-κB that regulate adipogenesis, antioxidant
and  anti-inflammatory  responses  [31].  Black  tea  polyphenols  inhibit  the  emulsion  of  droplets  and  the  activity  of
pancreatic lipase, α-amylase and glucosidases [32]. Green tea was reported to reduce significantly body mass index and
waist circumference. Furthermore, Vernarelli and Lambert [33] compared the intake of flavonoids with the Body Mass
Index (BMI) and waist circumference. The authors established that higher flavonoid intake influenced lower BMI and
waist  circumference,  which  could  contribute  to  the  health  issues  associated  with  obesity  as  a  higher  risk  for  many
chronic  diseases.  Cocoa  supplementation  and  cinnamon  reduce  blood  glucose.  Soy  isoflavones,  citrus  products,
hesperidin  and  quercetin  improve  lipid  metabolism  [34].
Increased consumption of polyphenol-rich foods and beverages was associated with a reduction of cardiovascular
diseases [35 - 37]. Furthermore, among polyphenol-rich foods and beverages, Arab et al. [38] associated a higher intake
of green or black tea with a lower risk of stroke and type 2 diabetes [39]. Increasing flavonoid intake also appeared to
be a way to reduce moderately the risk of disease as stroke [40]. Additionally, flavonoids have been reported to provide
both antioxidant and antithrombotic properties [41, 42].
Some of the most common sources of dietary polyphenols are given in Table 1.
Table 1. List of some major polyphenol compounds of plant origin.
Food Group Some Major Sources of Polyphenols
Fruit
oranges, apples, grapes, peaches, grapefruit juice, cherries, blueberries, pomegranate juice, raspberries, cranberries, black
elderberries, blackcurrants, plums, blackberries, strawberries, apricots
Vegetables spinach, onions, shallots, potatoes, black and green olives, globe artichoke heads, broccoli, asparagus, carrots
Whole grains whole grain wheat, rye, and oat flours
Nuts, seeds, and legumes roasted soybeans, black beans, white beans, chestnuts, hazelnuts, pecans, almonds, walnuts, flaxseed
Beverages coffee, tea, red wine
Fats dark chocolate, virgin olive oil, sesame seed oil
Spices and seasonings
cocoa powder, capers, saffron, dried oregano, dried rosemary, soy sauce, cloves, dried peppermint, star anise, celery seed,
dried sage, dried spearmint, dried thyme, dried basil, curry powder, dried ginger, cumin, cinnamon
Numerous scientific  reports  give evidence regarding the intake of  polyphenols  (and their  food sources)  and the
influence on related-diabetes risk factors.  Several  studies highlight  the anti-obesity effects  of  polyphenol-rich diets
affecting the ability of polyphenols to interact, directly or indirectly, with adipose tissues (preadipocytes, adipose stem
cells, and immune cells). However, obesity and diabetes nowadays are among the major diseases of health concern,
which provoke the scientific interest. Obese individuals are at a greater risk for the development of several pathologies
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including diabetes etc. [43], which show the relationship between both.
Polyphenols  (p-coumaric  acid,  m-coumaric  acid,  ferulic  acid  and  hydroxyhippuric  acid)  could  boost  insulin
sensitivity, slow down the rate, the digestion, and absorption of sugar [44]. Recent studies associate the decrease of the
insulin resistance to type of flavonoid (flavan-3-ols) and revealed the flavonoids as the type of polyphenols most often
associated with a lower risk for type 2 diabetes [45, 46]. Unfortunately, in order to state concrete flavonoids conducting
large-scale, well-designed, and population-based studies is required in the future [47].
Lambert et al. [48] evaluated a synergistic effect of grape polyphenols supplementation combined with the exercise
by increasing muscle lipid oxidation and sparing glycogen utilization, which resulted in enhancement of endurance
capacity based on the intensification of their individual metabolic effects. The reported, underlined the importance of
both  dietary  and  physical  training  recommendations  in  insulin  resistance  condition.  Furthermore,  the  use  of  a
combination of polyphenols is proposed to treat diabesity complications in view of reported synergisms of resveratrol
when combined with quercetin or resveratrol plus quercetin and genistein in in vitro studies [49, 50].
However, it is difficult such beneficial effects to be proven in in vivo experiments. Bruckbauer et al. [51] stated
synergisms during in vitro and in vivo approaches with other compounds, such as a leucine metabolite, methylxanthines
and metformin as potential therapeutic agents in obesity and diabetes prevention and management.
Resveratrol,  commonly  found  in  grapes,  berries,  and  some nuts,  is  one  of  the  most  commonly  used  nutritional
supplement  polyphenolic  compound  with  potent  antioxidant  activity.  Resveratrol  is  particularly  interesting  to  the
scientific field because of its health benefits associated with diseases such as cancer, type 2 diabetes, cardiovascular
disease,  and  neurological  conditions  [52].  This  polyphenol  gains  worldwide  interest  when  reports  of  its  cardio
protective effects  originating from red wine become available [53].  Resveratrol  was reported as a  potential  obesity
treatment as it can lead to lowering body weight [54]; reducing the fat mass by inhibiting adipogenesis. However, the
data on long-term resveratrol toxicity is contradictious [55, 56] even though clinical trials proved a well-tolerated and
pharmacologically safe dosage of up to 5 g/day [57]. Yet, the research of its bioavailability and effectiveness in vivo is
essential thus, the current data are still insufficient.
Retinopathy, nephropathy and neuropathy are only some of the serious health concern problems diabetes can cause
in the long term. Various anthocyanins, flavonoids and other polyphenolic compounds have been found with potential
preventive effects for improving the quality of life in the patients. Anthocyanins and anthocyanins-rich extracts have
been reported as potential to alleviate some pathologic conditions because of diabetes [58]. Flavanols, on the other
hand, were assumed as potential to improve cognitive disorders and cholinergic dysfunction related to diabetes and
other secondary consequence of changes in the nervous system induced by hyperglycemia and diabetes oxidative stress
and, as for example, quercetin was reported to improve mental function and memory in rats with diabetes [59].
Numerous  literature  data  support  the  natural  phenolic  compounds  as  health-beneficial  sources,  furthermore,
functional foods and dietary supplements containing phenolic compounds gain extensive publicity and interest as a
contemporary inexpensive therapeutic approach [60]. Based on the increased scientific interest, various research studies
are involved in the evaluation of the polyphenol dietary sources potential of fruit, vegetables, herbs and spices [61 - 64].
All  this  is  a  prerequisite  polyphenols  to  be  involved  in  novel  strategies  for  preventing  diabetes  and  obesity
complications  [65].
Certain dietary components and over 800 plants were claimed to help prevent or moderate metabolic syndrome by
assisting  the  body  homeostasis  mechanism  [66].  Phenolic  beneficial  effects  are  exacted  from  plants  belonging  to
taxonomic families such as Moraceae, Fabaceae, Asteraceae, Pyrus, Lauraceae, Lythraceae, and Malvaceae [67].
Possible pathways of polyphenol metabolism by intestinal bacteria [68] have been investigated in several research
projects, highlighting the significant evidence of the diet-derived bioactive metabolites produced by gut microbiota,
with  a  particular  emphasis  on  polyphenols  and  their  potential  impact  on  human  health.  In  this  regard,  the
characterization of  microbial  strains,  suitable  for  the  fermentation process  of  plants  historically  recognized by folk
medicine, could be used to design new functional food with added beneficial attributes [69, 70]. Furthermore, other
health  beneficial  functions  associated  with  obesity  symptoms  improvement  have  been  associated  with  maintaining
normal gut microbiota [71 - 73].
Microbial engineering is one of the alternative approaches, which can meet the global demand for natural products
in an eco-friendly manner [74]. Metabolic engineering of microorganisms could provoke microbial synthesis of many
plant polyphenols. However, recent technological innovations such as the development of biosensor-driven directed
224   The Open Biotechnology Journal, 2018, Volume 12 Mihaylova et al.
evolution  approaches  could  enable  the  rapid  engineering  of  microbial  host  strains  for  providing  more  precursor
molecules to increase polyphenol synthesis [75, 76]. New molecular techniques, as well as approaches and concepts
from synthetic biology, could be also employed to harmonize endogenous and heterologous pathways for maximizing
product  titers  and host  could improve rerouting of  carbon fluxes to and through polyphenol-providing pathways of
interest [77, 78].
In  particular,  nanotechnological  approaches  could  help  to  overcome  the  pharmacokinetic  issues  of  bioactive
compounds by providing improved bioavailability, overcoming the first-pass metabolism and trounce enterohepatic
recirculation, by protection against degradation, enhancement in intracellular penetration and control delivery, and by
reducing potential toxicity [79]. Stilbenes can be therefore used in a natural form for prevention or in their pure form of
therapy, for which large doses or nanoformulations are recommended [80].
4. FUTURE INSIGHT AND PERSPECTIVE
An intake of above 600 mg/d of polyphenols within a healthy dietary pattern, rich in fruits and vegetables has been
recommended. Future clinical and epidemiological studies are warranted to replicate these associations, especially using
biomarkers,  in  other  populations.  The  advances  in  polyphenols  research  will  be  important  to  make  dietary
recommendations for developing effective public health policies and for improving the autonomy and quality of life of
older people [81].
In addition, epidemiological studies and associated meta-analyses recommended the long-term consumption of rich
in  plant  polyphenols  diets  as  significant  protection  against  the  development  of  cancers,  cardiovascular  diseases,
diabetes, osteoporosis and neurodegenerative diseases [34, 82].
The measurement of phenolic metabolome in humans would point out which phenolic molecules are present in the
plasma/urine  of  humans  followed  the  intake  of  polyphenol-rich  foods  (green  tea,  cocoa,  citrus,  apple)  and  should
facilitate the provision of clearer evidence on the relations between food composition and risk of major chronic diseases
such as cancer, cardiovascular diseases or diabetes and shed new light on the causes of such diseases [83]. The future
research in this field should focus on the actual contribution of dietary polyphenols, new cellular and molecular targets
and on clarification of in vivo biotransformation processes, including analyses of the biological effects of each single
metabolite.
Applying  good practices  for  health  promotion  and  disease  prevention  through conscious  nutritious  choices  and
fostering a positive attitude towards nutrition. Sustainable diets are a key factor to long-term wellbeing and healthy
lifestyle.  Deepening  consumer’s  knowledge  will  create  healthy  eating  patterns  and  therefore  promote  personalized
nutrition.
CONCLUSION
Promoting healthier choices at an early stage of human development may lead to minimizing the display of 21st-
century  diseases  (i.e.  diabetes  type  2,  obesity,  heart  complications,  teeth  decay,  etc.)  based  on  adequate  dietary
assessment and food choices relevant to nutritional requirements.
Diabetes  and  obesity  are  issues  among serious  health  concern.  Both  conditions  are  strongly  associated  with  an
unhealthy  diet  and physical  inactivity.  Several  recent  studies  on  plant  deriving polyphenols  revealed  their  possible
beneficial effects on human health. Developing efficient public health policies and improving people’s quality of life by
personalized  nutrition,  based  on  the  recommendation  of  polyphenol  intake,  would  enhance  consumer’s  trust  in
sustainable  dietary  choices  lying  on  a  sound  scientific  basis.
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